PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28515684-0	2017	Selegiline Ameliorates Depression-Like Behavior in Mice Lacking the CD157/BST1 Gene, a Risk Factor for Parkinson"s Disease.	Selegiline	0-10	bone marrow stromal cell antigen 1	Mus musculus	68-73	
28515684-0	2017	Selegiline Ameliorates Depression-Like Behavior in Mice Lacking the CD157/BST1 Gene, a Risk Factor for Parkinson"s Disease.	Selegiline	0-10	bone marrow stromal cell antigen 1	Mus musculus	74-78	
28515684-2	2017	Selegiline is an irreversible monoamine oxidase-B (MAO-B) inhibitor, and is widely used in the treatment of PD and major depression.	Selegiline	0-10	monoamine oxidase B	Mus musculus	30-49	
28515684-2	2017	Selegiline is an irreversible monoamine oxidase-B (MAO-B) inhibitor, and is widely used in the treatment of PD and major depression.	Selegiline	0-10	monoamine oxidase B	Mus musculus	51-56	
28515684-5	2017	A single administration of selegiline (1-10 mg/kg) dose-dependently reduced immobility time in the forced swimming test (FST) in CD157 KO mice, but not C57BL/6N wild-type (WT) mice.	Selegiline	27-37	bone marrow stromal cell antigen 1	Mus musculus	129-134	
28515684-6	2017	At 10 mg/kg, but not 3 mg/kg, selegiline significantly increased climbing time in CD157 KO mice.	Selegiline	30-40	bone marrow stromal cell antigen 1	Mus musculus	82-87	
28515684-9	2017	After the FST, CD157 KO mice showed decreases in striatal and hippocampal serotonin (5-HT) content, cortical norepinephrine (NE) content, and plasma corticosterone concentration.	Serotonin	74-83	bone marrow stromal cell antigen 1	Mus musculus	15-20	
28515684-9	2017	After the FST, CD157 KO mice showed decreases in striatal and hippocampal serotonin (5-HT) content, cortical norepinephrine (NE) content, and plasma corticosterone concentration.	Norepinephrine	109-123	bone marrow stromal cell antigen 1	Mus musculus	15-20	
28515684-9	2017	After the FST, CD157 KO mice showed decreases in striatal and hippocampal serotonin (5-HT) content, cortical norepinephrine (NE) content, and plasma corticosterone concentration.	Corticosterone	149-163	bone marrow stromal cell antigen 1	Mus musculus	15-20	
28515684-11	2017	In the open field test (OFT), repeated administration of mirtazapine had anxiolytic effects, and selegiline nonsignificantly ameliorated anxiety-like behaviors in CD157 KO mice.	Selegiline	97-107	bone marrow stromal cell antigen 1	Mus musculus	163-168	
28515684-12	2017	In the social interaction and preference tests, repeated mirtazapine ameliorated the high anxiety and low sociability of CD157 KO mice, whereas selegiline did not.	Mirtazapine	57-68	bone marrow stromal cell antigen 1	Mus musculus	121-126	
28515684-13	2017	These results indicate that selegiline has antidepressant and mild anxiolytic effects in CD157 KO mice, and suggest that it is an effective antiparkinsonian drug for depressive and anxiety symptoms in PD patients with a CD157 single nucleotide polymorphism (SNP).	Selegiline	28-38	bone marrow stromal cell antigen 1	Mus musculus	89-94	
28515684-13	2017	These results indicate that selegiline has antidepressant and mild anxiolytic effects in CD157 KO mice, and suggest that it is an effective antiparkinsonian drug for depressive and anxiety symptoms in PD patients with a CD157 single nucleotide polymorphism (SNP).	Selegiline	28-38	bone marrow stromal cell antigen 1	Homo sapiens	220-225